Efficacy and Safety of Sirolimus in COVID-19 Infection
Condition(s):COVID 19Last Updated:September 9, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):COVID 19Last Updated:September 9, 2020Unknown status
Condition(s):Lupus Erythematosus, SystemicLast Updated:June 5, 2023Not yet recruiting
Condition(s):Relapsed Lymphoblastic Leukemia; Recurrent Adult Lymphoblastic Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Lymphoblastic LymphomaLast Updated:September 14, 2020Terminated
Condition(s):Hepatocellular CarcinomaLast Updated:June 1, 2016Completed
Condition(s):Vascular AnomalyLast Updated:March 24, 2023Recruiting
Condition(s):Solid Organ Transplant Recipients; Skin CancerLast Updated:October 10, 2023Not yet recruiting
Condition(s):Advanced Solid TumorsLast Updated:January 25, 2022Recruiting
Condition(s):Desmoid TumorLast Updated:June 26, 2023Completed
Condition(s):Kaposiform Hemangioendothelioma; Tufted Angioma; Superficial Vascular Anomalies; Superficial Lymphatic MalformationsLast Updated:March 15, 2024Recruiting
Condition(s):Graves OphthalmopathyLast Updated:March 15, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.